University Hospital Augsburg is with about 1,750 beds one of the largest medical centers in Germany located in Augsburg. It is a teaching hospital of the Universität Augsburg and the only hospital of maximal care in Swabia. The hospital has two locations in Augsburg.

There are 1,737 beds in Klinikum Augsburg.

During the past decade, Klinikum Augsburg conducted 85 clinical trials. In the 10-year time frame, 85 clinical trials started and 13 clinical trials were completed, i.e. on average, 15.3% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 11 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Augsburg" #1 sponsor was "Universitätsklinikum Hamburg-Eppendorf" with 6 trials, followed by "Boehringer Ingelheim" with 5 trials sponsored, "German CLL Study Group" with 5 trials sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 5 trials sponsored and "Hoffmann-La Roche" with 5 trials sponsored. Other sponsors include 115 different institutions and companies that sponsored additional 95 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Augsburg" #1 collaborator was "Deutsche Kinderkrebsstiftung" with 3 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 2 trials as a collaborator, "ClinAssess GmbH" with 2 trials as a collaborator, "German Research Foundation" with 2 trials as a collaborator and "Hoffmann-La Roche" with 2 trials as a collaborator. Other collaborators include 99 different institutions and companies that were collaborators in the rest 105 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Augsburg" are "Intracranial Aneurysm" (9 trials), "Lymphoma" (9 trials), "Leukemia" (5 trials), "Aortic Stenosis" (4 trials) and "Chronic Lymphocytic Leukemia" (4 trials). Many other conditions were trialed in "Klinikum Augsburg" in a lesser frequency.

Most popular intervention types in "Klinikum Augsburg" are "Drug" (81 trials), "Device" (24 trials), "Biological" (22 trials), "Procedure" (17 trials) and "Radiation" (17 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (13 trials), "Placebo" (12 trials), "cyclophosphamide" (12 trials), "vincristine sulfate" (11 trials) and "doxorubicin hydrochloride" (10 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Augsburg" are 137 trials for "All" genders, 8 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Klinikum Augsburg". undefined are not yet recruiting, 35 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 71 completed trials in Klinikum Augsburg, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Augsburg, 8 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 56 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 17 trials that are defined as “Not Applicable".

Klinikum Augsburg has several departments that took part in Clinical trials: "Klinikum Augsburg, Schwäbisches Kinderkrebszentrum, I. Klinik für Kinder und Jugendliche, Hämatologie / Onkologie" - 4 trials, "Klinikum Augsburg - Klinik für Anästhesiologie und operative Intensivmedizin" - 2 trials, "Children's Hospital Augsburg Klinikum" - 2 trials